This is a website for healthcare professionals.
Leadership and Board of Directors
President & CEO
Fortunato Ron Rocca has served as our President and Chief Executive Officer and as a member of our board of directors since December 2011. From 2005 to October 2011,...
Dr. Thierry Dervieux
Chief Scientific Officer, Medical Director, New York
Thierry Dervieux, Ph.D. has served as our Chief Scientific Officer and Medical Laboratory Director since October 2010. Dr. Dervieux has nearly 20 years of experience...
Chief Financial Officer
Kamal Adawi has served as our Chief Financial Officer since June 2017. Kamal previously held the positions of Chief Financial Officer, Corporate Secretary and...
Arthur Weinstein, M.D.
Chief Medical Officer
Arthur Weinstein, M.D. has served as our Chief Medical Officer since October 2017 and has been a member of our board of directors since December 2013. Dr. Weinstein...
Senior Vice President Laboratory Operations
Claudia Ibarra has served as our Senior Vice President, Laboratory Operations since January 2017, after being our Vice President, Laboratory Operations from 2014. She...
Vice President of Finance
Mark Hazeltine has served as our Vice President of Finance since June 2017. Mr. Hazeltine served as Exagen’s Sr. Director of Financial Planning and Analysis...
Vice President, Information Services
Brian Littlefield has served as our Vice President, Information Services since April 2014. Prior to joining Exagen, Mr. Littlefield served as the Senior Director,...
Vice President of Marketing
Brian McEvilly has served as our Vice President of Marketing since February 2016. Brian joined us with nearly 20 years of medical marketing experience including his...
Tami Powell (York)
Vice President, Corporate Payer and Reimbursement Strategy
Tami Powell has served as our Vice President of Corporate Payer and Reimbursement Strategy since September 2017, after being our Senior Director, Corporate Payer...
Vice President, Sales & Managed Markets
John Wegener has served as our Vice President, Sales and Managed Markets since November 2013. Prior to joining Exagen, Mr. Wegener served in various capacities with...
Board of Directors
Mr. Stokes has served as the Chief Financial Officer of Castle Biosciences, Inc., a skin cancer diagnostics company, since December 2017. From January 2017 to December 2017, Mr. Stokes served as Chief Financial Officer of Hammock Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of women's health and urology products. From May 2011 to December 2016, Mr. Stokes served as a Managing Director of Leerink Swann (now SVB Leerink). Mr. Stokes also held positions as a Managing Director at Robert W. Baird & Co. Incorporated and Wachovia Securities, LLC. While at SVB Leerink and Robert W. Baird & Co., Mr. Stokes led life sciences, tools and diagnostics sector investment banking efforts and managed financings and mergers and acquisitions transactions. Mr. Stokes obtained a Bachelor of Science in Business Administration, Master of Business Administration and Doctor of Jurisprudence, all from the University of North Carolina at Chapel Hill.
Mr. Kim currently serves as Chief Financial Officer of Fulgent Genetics (Nasdaq: FLGT), a full-service genomic testing company built around a foundational technology platform. He has held that position since February 2016 and led growth initiatives, increasing revenues from $10M in 2015 to $990M in 2021, during the COVID-19 era. Mr. Kim has over 30 years working in accounting and finance, and over 15 years as a Chief Financial Officer of several publicly traded companies. Mr. Kim is a Certified Public Accountant and a graduate of the University of California at Berkeley.